CALRX Trademark

Trademark Overview

On Friday, July 15, 2022, a trademark application was filed for CALRX with the United States Patent and Trademark Office. The USPTO has given the CALRX trademark a serial number of 97505046. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Thursday, March 20, 2025. This trademark is owned by California Department of Health Care Access and Information. The CALRX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, insulin
calrx

General Information

Serial Number97505046
Word MarkCALRX
Filing DateFriday, July 15, 2022
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateThursday, March 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, insulin
Pseudo MarkCALIFORNIA RX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCalifornia Department of Health Care Access and Information
Party Type10 - Original Applicant
Legal Entity Type14 - State Agency
AddressSacramento, CA 95833

Trademark Events

Event DateEvent Description
Tuesday, July 19, 2022NEW APPLICATION ENTERED
Thursday, August 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 1, 2023ASSIGNED TO EXAMINER
Thursday, May 4, 2023NON-FINAL ACTION WRITTEN
Thursday, May 4, 2023NON-FINAL ACTION E-MAILED
Thursday, May 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 13, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, July 13, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, July 17, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, July 17, 2023DIVISIONAL REQUEST RECEIVED
Friday, August 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 30, 2023DIVISIONAL PROCESSING COMPLETE
Monday, October 2, 2023ATTORNEY REVIEW COMPLETED
Thursday, October 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 27, 2023FINAL REFUSAL WRITTEN
Monday, November 27, 2023FINAL REFUSAL E-MAILED
Monday, November 27, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 20, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, February 20, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, May 28, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 28, 2024EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, May 28, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, May 28, 2024EX PARTE APPEAL-INSTITUTED
Wednesday, June 5, 2024ASSIGNED TO EXAMINER
Tuesday, July 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 30, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, July 30, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 7, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, August 14, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 14, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 22, 2024ATTORNEY REVIEW COMPLETED
Wednesday, January 8, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 8, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 14, 2025NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Friday, February 14, 2025SUBSEQUENT FINAL REFUSAL WRITTEN
Friday, February 14, 2025SUBSEQUENT FINAL EMAILED
Thursday, March 20, 2025ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, March 20, 2025EXPARTE APPEAL DISMISSED
Thursday, March 20, 2025EXPARTE APPEAL TERMINATED
Thursday, March 20, 2025ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL

Related Keywords

calrx insulin namely preparations pharmaceutical